Ivone U.S. Leong

Reporting pharmacogenetic variants and cancer WGS data could guide safer prescribing

Ben Westphalen, Oncologist with a specialization in Precision Oncology and Serving as chair of the Precision Medicine Working Group at European Society for Medical Oncology, shared an article by Ivone U.S. Leong  post on X:

“The power of Big Data in this Open Access research paper in Journal of Clinical Oncology.

Data from the 100,000 Genomes Project suggests that reporting pharmacogenetic (PGx) variants + cancer WGS data could guide safer prescribing.”

Large-Scale Pharmacogenomics Analysis of Patients With Cancer Within the 100,000 Genomes Project Combining Whole-Genome Sequencing and Medical Records to Inform Clinical Practice.

Authors: Ivone U.S. Leong, et al.

Reporting pharmacogenetic variants and cancer WGS data could guide safer prescribing

 

Ben Westphalen cancer Ivone U.S. Leong Journal of Clinical Oncology OncoDaily Oncology PGx variants pharmacogenomics WGS data